Bio Green Med Solution (BGMS) Net Cash Flow (QoQ) (2010 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.20 Bn | 133.34 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.81 Bn | 78.81 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.99 Bn | 59.80 Bn | 1.37 Bn |
| 4 | Moderna | 57.45 Bn | 52.31 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.65 Bn | 44.65 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.43 Bn | 32.12 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.18 Bn | 27.35 Bn | - |
| 9 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 10 | Bio Green Med Solution | 4.87 Mn | 1.08 Mn | 79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 341.95% |
| Mar 31, 2026 | 40.41% |
| Dec 31, 2025 | 33.18% |
| Sep 30, 2025 | -153.03% |
| Jun 30, 2025 | 106.52% |
| Mar 31, 2025 | 55.25% |
| Dec 31, 2024 | 108.38% |
| Sep 30, 2024 | -195.73% |
| Jun 30, 2024 | 670.28% |
| Mar 31, 2024 | 80.69% |
| Dec 31, 2023 | 28.76% |
| Sep 30, 2023 | -201.33% |
| Jun 30, 2023 | 80.40% |
| Mar 31, 2023 | -34.91% |
| Dec 31, 2022 | 5.68% |
| Sep 30, 2022 | -1,124.32% |
| Jun 30, 2022 | 93.50% |
| Mar 31, 2022 | -86.38% |
| Dec 31, 2021 | -10.53% |
| Sep 30, 2021 | 21.15% |